| COOPER COMPANIES |
| USA |
| Gesundheit |
| US2166485019 / A402VX |
| CP60 (Frankfurt) / COO (NASDAQ) |
| FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO |
| - |
| https://www.coopercos.com.. |
|
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, ..
>Volltext.. |
| 11687.81 Mio. EUR |
| 13668.32 Mio. EUR |
| 3643.65 Mio. EUR |
| 993.95 Mio. EUR |
| 203.06 Mio. EUR |
| 1.03 EUR |
| 2118.62 Mio. EUR |
| 119.7 Mio. EUR |
| 820.69 Mio. EUR |
| 0.08 |
| 2.42% |
| -45.04% |
| - |
| - |
| - |
| 26.07.23 - 0.00160875€ 20.01.23 - 0.00160875€ >weitere anzeigen... |
| - |
| COOPER COMPANIES, COOPERCOMPANIES, COOPER COS |
| 09.09.26 |
|